AI Firm - Tech Shelf

AstraZeneca and Absci partnership paves the way for AI-generated cancer antibodies, potentially eliminating the need for chemotherapy

December 4, 2023admin

AstraZeneca and Absci have signed a deal worth $247 million to collaborate on developing cancer antibodies using generative AI, reports Reuters. AstraZeneca aims to replace chemotherapy and sees this partnership as a significant step towards achieving that goal. They plan to use Absci’s AI technology for large-scale protein analysis to search for a workable cancer […]

AI Firms May Face Shortage of Training Data, Warn Researchers

November 18, 2023admin

AI Firms Could Run Out of Training Data: The Crisis and Potential Mitigation Strategies The burgeoning AI industry faces a pivotal challenge – the impending scarcity of high-quality training data. AI models depend on an abundance of diverse and natural data, but the industry is realizing that this essential resource is finite, potentially leading to […]

Tag: AI Firm

AstraZeneca and Absci partnership paves the way for AI-generated cancer antibodies, potentially eliminating the need for chemotherapy

AI Firms May Face Shortage of Training Data, Warn Researchers

About Us

Latest Post

Helpful Links